glp-1 receptor agonist pancreatitis risk meta-analysis Frontiers GLP1 Receptor Agonists—Effects beyond Obesity

To make matters worse, studies show that the benefits on weight fade or diminish sharply when the treatment is stopped, so it would have to be continued long-term

Another approach is to launch products that are nutrient-dense and portion-controlled for both GLP-1 RA users and individuals tapering off the medication who continue to sustain weight loss whilst preserving muscle mass

If you experience severe abdominal pain, jaundice, or difficulty passing gas while on these medications, seek immediate medical attention, as these symptoms could indicate serious issues like pancreatitis or gallbladder complications

PMID: 22215523

doi: 10.1038/nrn2867 31 CollinsS

4 Receptor binding activates adenylate cyclase causing intracellular accumulation of cyclic adenosine monophosphate (cAMP), which activates protein kinase A (PKA) and triggers insulin secretion